Back to results
US 2013/0261122 A1Published application
Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase Inhibitors
AssigneeN30 Pharmaceuticls, Inc.
InventorsXicheng Sun, Jian Qiu, Adam Stout
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel substituted bicyclic aromatic compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
Claims32
The compound of Formula 1:
- Wherein
- R1 is selected from the group consisting of H, F, and Cl;
- R2a and R2b are independently selected from the group consisting of H, F, Cl, Br, Me, OCH3, and cyano;
- R2c is selected from the group consisting of H, F, Cl, Br, Me, and OCH3;
- X is selected from the group consisting of
- A is selected from the group consisting of
- R3 is selected from the group consisting of F, Cl, Br, CH3, CF3, OCH3, cyano, N(CH3)2, and morpholino;
- n is selected from the group consisting of 0, 1, and 2;
- R4 is selected from the group consisting of H, F, Cl, Br, CH3, CF3, OCH3, cyano, N(CH3)2, and morpholino;
- with the proviso that when X is
- and A is COOH, then at least one of R1, R2a, R2b, R2c, and R4 is not hydrogen, or n must be >0, and R3 when meta to naphthalene, cannot be CH3.
8 more elements
Dependencies are inferred from the claim text.